Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Review article · 27 Jan 2022 Conference abstract · 15 Aug 2011 A synergitic effect of therapeutic stem cells expressing a suicide enzyme, sytosine deaminase, with a prodrug and interferon-beta in the inhibition of endometrial cancer cell growth In vitro
recent, gene-directed enzyme/prodrug theraphies (GEPT) have been highly regarded as an alternative means of gene therapy in anti-cancer treatments. As one of GEPT, cytosine deaminse ... fluorocytosine (5-FC) system…
Conference abstract · 26 Jun 2013 Study of mesenchymal stem cells from umbilical cord tissue- A promising approach to human future
clinical concepts in supporting cellular theraphy. This leads to the purpose to find an alternative source of Mesenchymal Stem Cells as collection of MSC from bone marrow involves an invasive
Conference abstract · 15 Aug 2011 A synergitic effect of therapeutic stem cells expressing a suicide enzyme, sytosine deaminase, with a prodrug and interferon-beta in the inhibition of endometrial cancer cell growth In vitro
recent, gene-directed enzyme/prodrug theraphies (GEPT) have been highly regarded as an alternative means of gene therapy in anti-cancer treatments. As one of GEPT, cytosine deaminse ... fluorocytosine (5-FC) system…
Conference abstract · 25 Jul 2016 Formulation of Nanocomposite drug containing fine ZnO Q-dots, and consideration of invitro cytotoxity evaluation of mouth KB44, breast MCF7, colon HT29, and HeLa Cancer Cell Lines, and invivo mouse ear swelling tests
fine porous ZnO Q-dots could be generated strong potential medical applications in cancer theraphy. In the present research, a typical zinc oxide quantum dots nanoparticles (QD NPs) was synthesized ... blue shift…
Short communication · 2020 Developing job of MMR, MSI, TMB and neoantigen testing in malignant growth patients getting immunotherapy
Malignant growth is one of the most deadly illnesses and is causing
Research article · 2012 Long-Term Effectiveness of First-Line Antiretroviral Theraphy in a Cohort of HIV-1 Infected Patients
Background: Eligibility criteria might explain differences in viral response to combined antiretroviral

